E Fund Management Co., Ltd. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$238
-43.6%
10,599
+2.0%
0.02%
-45.5%
Q2 2023$422
-0.2%
10,387
+19.0%
0.03%
+6.5%
Q1 2023$4230.0%8,732
-21.2%
0.03%
-11.4%
Q4 2022$423
-99.9%
11,083
+24.8%
0.04%
-16.7%
Q3 2022$446,000
-17.9%
8,881
-34.5%
0.04%
-14.3%
Q2 2022$543,000
+86.0%
13,553
+73.1%
0.05%
+390.0%
Q1 2022$292,0007,8300.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders